Patents by Inventor Martin Lipkin

Martin Lipkin has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Extracts of orange peel for prevention and treatment of cancer
    Patent number: 7201928
    Abstract: Compositions and methods of inhibiting tumor cell growth and treating and preventing cancer are provided based on administration of an orange peel extract either alone or in combination with other phytochemicals.
    Type: Grant
    Filed: September 20, 2000
    Date of Patent: April 10, 2007
    Assignee: Rutgers, The State University of New Jersey
    Inventors: Mou Tuan Huang, Chi-Tang Ho, Robert T. Rosen, Geetha Ghai, Martin Lipkin, Kuang Yu Chen, Nitin Telang, Charles Boyd, Katalin Csiszar
  • Resveratrol analogs for prevention of disease
    Patent number: 6790869
    Abstract: Compositions and methods for prevention or treatment of disease are provided which comprise analogs of Resveratrol.
    Type: Grant
    Filed: May 18, 2001
    Date of Patent: September 14, 2004
    Assignee: Rutgers, The State University of New Jersey
    Inventors: Geetha Ghai, Kuang Yu Chen, Robert T. Rosen, Mingfu Wang, Nitin Telang, Martin Lipkin, Chi-Tang H
  • Resveratrol analogs for prevention of disease
    Publication number: 20020028852
    Abstract: Compositions and methods for prevention or treatment of disease are provided which comprise analogs of Resveratrol.
    Type: Application
    Filed: May 18, 2001
    Publication date: March 7, 2002
    Inventors: Geetha Ghai, Kuang Yu Chen, Robert T. Rosen, Mingfu Wang, Nitin Telang, Martin Lipkin, Chi-Tang Ho
  • Method for growth in tissue culture of normal colonic epithelial cells and method for determination of preneoplastic color cells
    Patent number: 4743552
    Abstract: The invention concerns a method for the routine primary culture of human colonic epithelial cells within a monolayer. 12-0-tetradecanoylphorbol-13-acetate (TPA) enhanced DNA synthesis an average of 8 fold when assayed by [.sup.3 h]dThd labeling indices (L.I.) in colonic epithelial cells from familial polyposis patients and in tubular adenomas. No such stimulation by TPA was seen in cells from high-risk patients without familial polyposis, or in cells from low-risk subjects.
    Type: Grant
    Filed: September 26, 1984
    Date of Patent: May 10, 1988
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Eileen A. Friedman, Martin Lipkin